News Conference News TCT 2023 ‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big Todd Neale October 25, 2023
Presentation TCT 2023 PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval Presenter: Nir Uriel October 25, 2023
News Conference News TCT 2023 More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact Yael L. Maxwell October 24, 2023
Presentation TCT 2023 Overcoming the "Credibility Crisis" of Observational Data Presenter: Robert Yeh October 24, 2023
Presentation TCT 2023 The FDA Total lifecycle Advisory Program (FDA-TAP) Presenter: April Marrone October 24, 2023
Presentation TCT 2023 Understanding the New Technology Add-on Payments Program (NTAP) Presenter: Dominic Allocco October 24, 2023
Presentation TCT 2023 Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET) Presenter: Steven Farmer October 24, 2023
Presentation TCT 2023 State of the FDA CDRH: Challenges, Opportunities, and Future Projections for Device Innovation, Approval, and Implementation Presenter: Bram Zuckerman October 24, 2023
News Opinion Off Script A New Cardiovascular Board? A Few Things For Cardiology Leaders to Consider Westby G. Fisher, MD October 20, 2023
News Daily News FDA Scolds Abiomed for Not Seeking a PMA for Its Web-Based User Portal Caitlin E. Cox October 17, 2023
News Daily News Patient ‘Progressing Well’ After Second Pig-to-Human Heart Transplant Yael L. Maxwell September 26, 2023
News Daily News FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI L.A. McKeown September 12, 2023
News Conference News ESC 2023 ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems Todd Neale August 27, 2023
News Daily News Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel L.A. McKeown August 23, 2023
News Daily News ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel L.A. McKeown August 22, 2023
News Daily News As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions L.A. McKeown August 18, 2023